Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer Lead Investing
CMX Options Exercised, New Options Granted And Promotional Activities Contract Precious Metals Investing
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema Lead Investing
Ero Copper to Release Third Quarter 2025 Operating and Financial Results on November 4, 2025 Zinc Investing
Relmada Therapeutics Appoints Distinguished Urologic Oncologist, Max Kates, MD, to the Clinical Advisory Board to Support Development of NDV-01 Lead Investing
